Russell Frank Company’s Enanta Pharmaceuticals ENTA Stock Holding History

Russell Frank Company’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.75M	Buy	93,781 +20,552	+28%	+$572K	﹤0.01%	1687
2015 Q4	$2.45M	Sell	73,229 -4,424	-6%	-$144K	﹤0.01%	1711
2015 Q3	$2.81M	Buy	77,653 +8,088	+12%	+$347K	0.01%	1646
2015 Q2	$3.13M	Buy	69,565 +57,979	+500%	+$2.26M	0.01%	1717
2015 Q1	$355K	Sell	11,586 -39,513	-77%	-$1.54M	﹤0.01%	2499
2014 Q4	$2.61M	Buy	51,099 +5,662	+12%	+$253K	﹤0.01%	1633
2014 Q3	$1.8M	Sell	45,437 -1,596	-3%	-$63.6K	﹤0.01%	1792
2014 Q2	$1.77M	Buy	47,033 +4,427	+10%	+$169K	﹤0.01%	1821
2014 Q1	$1.59M	Buy	42,606 +2,460	+6%	+$89.4K	﹤0.01%	1876
2013 Q4	$1.47M	Buy	40,146 +40,126	+200,630%	+$972K	﹤0.01%	1891
2013 Q3	$0	Buy	+20	New	+$382	﹤0.01%	3458

Other funds holding ENTA

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Russell Frank Company's ENTA Position: Q1 2016 in Review

Russell Frank Company increased its Enanta Pharmaceuticals (ENTA) stake by 28% in Q1 2016, buying an estimated $572K and bringing the position to 93,781 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

Russell Frank Company first reported a position in ENTA in Q3 2013 and has held it in 11 quarters since. The position peaked at $3.13M in Q2 2015. 152 funds tracked by Wall St. Rank hold ENTA as of Q1 2016.

Russell Frank Company held 93,781 shares of Enanta Pharmaceuticals worth $2.75M as of Q1 2016.
Russell Frank Company bought 20,552 Enanta Pharmaceuticals shares in Q1 2016, an estimated $572K.
Enanta Pharmaceuticals made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1687 holding.
Russell Frank Company first reported a position in Enanta Pharmaceuticals in Q3 2013 and has held it in 11 quarters since.
Russell Frank Company's Enanta Pharmaceuticals position peaked at $3.13M in Q2 2015.
152 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.